Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Apr;59(4):499–502. doi: 10.1038/bjc.1989.103

Increased breakage of chromosome 1 in lymphocytes of patients with testicular cancer after bleomycin treatment in vitro.

I Vorechovsky 1, J Zaloudik 1
PMCID: PMC2247150  PMID: 2469452

Abstract

Chromosome damage in vitro after bleomycin treatment during the late S and G2 phases of the cell cycle was studied in the peripheral lymphocytes of 19 untreated patients with primary testicular tumours and 22 age-matched healthy men with no excess of cancer incidence in the families. The occurrence of spontaneous chromosome aberrations was not shown to be different in the studied groups. However, in the lymphocytes treated with bleomycin, cancer patients exhibited higher numbers of break events per cell (1.06 versus 0.67, P less than 0.01) and increased frequency of cells with aberrations (55.0 versus 43.0, P less than 0.05) than control group. Aberrant cells of cancer patients had more aberrations than cells of the control sample (1.79 versus 1.53, P less than 0.01). The frequency of chromosome 1 aberrations, often encountered in cancer cells of testicular and other solid tumours, was significantly higher in lymphocytes of patients with testicular cancer (15.0 versus 8.4%, P less than 0.0001), the long arm of this chromosome being predominantly affected (12.0 versus 6.3%, P less than 0.0001). These results support the view that a genome disposed to testicular cancer is less effective in the ability to repair non-specific DNA damage in this region, more susceptible to damage, or both.

Full text

PDF
499

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alalawi F. A., Chapman I. V. Combined effects of bleomycin and X-rays on DNA synthesis in asynchronous Ehrlich ascites cells in suspension. Br J Cancer. 1977 Jul;36(1):78–83. doi: 10.1038/bjc.1977.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atkin N. B., Baker M. C. i(12p): specific chromosomal marker in seminoma and malignant teratoma of the testis? Cancer Genet Cytogenet. 1983 Oct;10(2):199–204. doi: 10.1016/0165-4608(83)90125-5. [DOI] [PubMed] [Google Scholar]
  3. Atkin N. B. Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet. 1986 Apr 15;21(4):279–285. doi: 10.1016/0165-4608(86)90206-2. [DOI] [PubMed] [Google Scholar]
  4. Bohr V. A., Phillips D. H., Hanawalt P. C. Heterogeneous DNA damage and repair in the mammalian genome. Cancer Res. 1987 Dec 15;47(24 Pt 1):6426–6436. [PubMed] [Google Scholar]
  5. Cherry L. M., Hsu T. C. Bleomycin-induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members. Anticancer Res. 1983 Nov-Dec;3(6):367–372. [PubMed] [Google Scholar]
  6. Delozier-Blanchet C. D., Walt H., Engel E., Vuagnat P. Cytogenetic studies of human testicular germ cell tumours. Int J Androl. 1987 Feb;10(1):69–77. doi: 10.1111/j.1365-2605.1987.tb00167.x. [DOI] [PubMed] [Google Scholar]
  7. Dieckmann K. P., Becker T., Jonas D., Bauer H. W. Inheritance and testicular cancer. Arguments based on a report of 3 cases and a review of the literature. Oncology. 1987;44(6):367–377. doi: 10.1159/000226513. [DOI] [PubMed] [Google Scholar]
  8. Gantt R., Parshad R., Price F. M., Sanford K. K. Biochemical evidence for deficient DNA repair leading to enhanced G2 chromatid radiosensitivity and susceptibility to cancer. Radiat Res. 1986 Nov;108(2):117–126. [PubMed] [Google Scholar]
  9. Gantt R., Sanford K. K., Parshad R., Price F. M., Peterson W. D., Jr, Rhim J. S. Enhanced G2 chromatid radiosensitivity, an early stage in the neoplastic transformation of human epidermal keratinocytes in culture. Cancer Res. 1987 Mar 1;47(5):1390–1397. [PubMed] [Google Scholar]
  10. Hsu T. C., Cherry L. M., Samaan N. A. Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet Cytogenet. 1985 Aug;17(4):307–313. doi: 10.1016/0165-4608(85)90114-1. [DOI] [PubMed] [Google Scholar]
  11. Hsu T. C. Genetic instability in the human population: a working hypothesis. Hereditas. 1983;98(1):1–9. doi: 10.1111/j.1601-5223.1983.tb00574.x. [DOI] [PubMed] [Google Scholar]
  12. Hsu T. C. Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro Cell Dev Biol. 1987 Sep;23(9):591–603. doi: 10.1007/BF02621067. [DOI] [PubMed] [Google Scholar]
  13. Hsu T. C., Ramkissoon D., Furlong C. Differential susceptibility to a mutagen among human individuals: synergistic effect on chromosome damage between bleomycin and aphidicolin. Anticancer Res. 1986 Sep-Oct;6(5):1171–1175. [PubMed] [Google Scholar]
  14. Parshad R., Gantt R., Sanford K. K., Jones G. M. Chromosomal radiosensitivity of human tumor cells during the G2 cell cycle period. Cancer Res. 1984 Dec;44(12 Pt 1):5577–5582. [PubMed] [Google Scholar]
  15. Parshad R., Gantt R., Sanford K. K., Jones G. M., Tarone R. E. Repair of chromosome damage induced by X-irradiation during G2 phase in a line of normal human fibroblasts and its malignant derivative. J Natl Cancer Inst. 1982 Aug;69(2):409–414. [PubMed] [Google Scholar]
  16. Parshad R., Sanford K. K., Jones G. M. Chromatid damage after G2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5612–5616. doi: 10.1073/pnas.80.18.5612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sanford K. K., Tarone R. E., Parshad R., Tucker M. A., Greene M. H., Jones G. M. Hypersensitivity to G2 chromatid radiation damage in familial dysplastic naevus syndrome. Lancet. 1987 Nov 14;2(8568):1111–1116. doi: 10.1016/s0140-6736(87)91546-7. [DOI] [PubMed] [Google Scholar]
  18. Senturia Y. D. The epidemiology of testicular cancer. Br J Urol. 1987 Oct;60(4):285–291. doi: 10.1111/j.1464-410x.1987.tb04970.x. [DOI] [PubMed] [Google Scholar]
  19. Sikic B. I. Biochemical and cellular determinants of bleomycin cytotoxicity. Cancer Surv. 1986;5(1):81–91. [PubMed] [Google Scholar]
  20. Wang N., Trend B., Bronson D. L., Fraley E. E. Nonrandom abnormalities in chromosome 1 in human testicular cancers. Cancer Res. 1980 Mar;40(3):796–802. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES